Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK Inhibition

Z. Parackova, P. Vrabcova, I. Zentsova, A. Sediva, M. Bloomfield

. 2023 ; 43 (7) : 1640-1659. [pub] 20230626

Language English Country Netherlands

Document type Journal Article, Research Support, Non-U.S. Gov't

STAT1 gain-of-function (GOF) mutations cause an inborn error of immunity with diverse phenotype ranging from chronic mucocutaneous candidiasis (CMC) to various non-infectious manifestations, the most precarious of which are autoimmunity and vascular complications. The pathogenesis centers around Th17 failure but is far from being understood. We hypothesized that neutrophils, whose functions have not been explored in the context of STAT1 GOF CMC yet, might be involved in the associated immunodysregulatory and vascular pathology. In a cohort of ten patients, we demonstrate that STAT1 GOF human ex-vivo peripheral blood neutrophils are immature and highly activated; have strong propensity for degranulation, NETosis, and platelet-neutrophil aggregation; and display marked inflammatory bias. STAT1 GOF neutrophils exhibit increased basal STAT1 phosphorylation and expression of IFN stimulated genes, but contrary to other immune cells, STAT1 GOF neutrophils do not display hyperphosphorylation of STAT1 molecule upon stimulation with IFNs. The patient treatment with JAKinib ruxolitinib does not ameliorate the observed neutrophil aberrations. To our knowledge, this is the first work describing features of peripheral neutrophils in STAT1 GOF CMC. The presented data suggest that neutrophils may contribute to the immune pathophysiology of the STAT1 GOF CMC.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23016142
003      
CZ-PrNML
005      
20231026110321.0
007      
ta
008      
231013s2023 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s10875-023-01528-1 $2 doi
035    __
$a (PubMed)37358695
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Parackova, Zuzana $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, 515006, Prague, Czech Republic. zuzana.parackova@lfmotol.cuni.cz $1 https://orcid.org/000000022398532X $7 xx0231004
245    10
$a Neutrophils in STAT1 Gain-Of-Function Have a Pro-inflammatory Signature Which Is Not Rescued by JAK Inhibition / $c Z. Parackova, P. Vrabcova, I. Zentsova, A. Sediva, M. Bloomfield
520    9_
$a STAT1 gain-of-function (GOF) mutations cause an inborn error of immunity with diverse phenotype ranging from chronic mucocutaneous candidiasis (CMC) to various non-infectious manifestations, the most precarious of which are autoimmunity and vascular complications. The pathogenesis centers around Th17 failure but is far from being understood. We hypothesized that neutrophils, whose functions have not been explored in the context of STAT1 GOF CMC yet, might be involved in the associated immunodysregulatory and vascular pathology. In a cohort of ten patients, we demonstrate that STAT1 GOF human ex-vivo peripheral blood neutrophils are immature and highly activated; have strong propensity for degranulation, NETosis, and platelet-neutrophil aggregation; and display marked inflammatory bias. STAT1 GOF neutrophils exhibit increased basal STAT1 phosphorylation and expression of IFN stimulated genes, but contrary to other immune cells, STAT1 GOF neutrophils do not display hyperphosphorylation of STAT1 molecule upon stimulation with IFNs. The patient treatment with JAKinib ruxolitinib does not ameliorate the observed neutrophil aberrations. To our knowledge, this is the first work describing features of peripheral neutrophils in STAT1 GOF CMC. The presented data suggest that neutrophils may contribute to the immune pathophysiology of the STAT1 GOF CMC.
650    _2
$a lidé $7 D006801
650    _2
$a autoimunita $7 D015551
650    12
$a kandidóza chronická mukokutánní $x farmakoterapie $x genetika $7 D002178
650    12
$a aktivační mutace $7 D000073659
650    _2
$a neutrofily $x metabolismus $7 D009504
650    _2
$a fenotyp $7 D010641
650    _2
$a fosforylace $7 D010766
650    12
$a transkripční faktor STAT1 $x metabolismus $7 D050794
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vrabcova, Petra $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, 515006, Prague, Czech Republic
700    1_
$a Zentsova, Irena $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, 515006, Prague, Czech Republic
700    1_
$a Sediva, Anna $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, 515006, Prague, Czech Republic
700    1_
$a Bloomfield, Marketa $u Department of Immunology, 2nd Faculty of Medicine Charles University, University Hospital in Motol, V Uvalu 84, 515006, Prague, Czech Republic
773    0_
$w MED00002589 $t Journal of clinical immunology $x 1573-2592 $g Roč. 43, č. 7 (2023), s. 1640-1659
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37358695 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231013 $b ABA008
991    __
$a 20231026110315 $b ABA008
999    __
$a ok $b bmc $g 1999956 $s 1202504
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2023 $b 43 $c 7 $d 1640-1659 $e 20230626 $i 1573-2592 $m Journal of clinical immunology $n J Clin Immunol $x MED00002589
LZP    __
$a Pubmed-20231013

Find record

Citation metrics

Logged in users only

Archiving options

Loading data ...